Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AR101 in peanut allergy (PALISADE)
NCT02635776Phase 3Completed
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Allergy Immunotherapy
- Countries
- 10
01
Overview
A Phase 3 trial of peanut protein in peanut allergy. Started Dec 2015; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT02635776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02635776.